Vox Sanguinis · 1997 · 26 citations · 5 references
Life SciencesHematologyImmunologyClinical ImmunologyImmunopathologyImmunotechnologyAntibody CharacterizationAutoantibodiesFlow CytometryImmunoassay AnalysisImmunoassay DevelopmentAgglutination ReactionsAntibodiesFlow Cytometric AnalysisFlow Cytometric Immune PhenotypingFlow Cytometric ImmunophenotypingFlow Cytometry AntibodiesFlow Cytometry ImmunophenotypingNeonatal Hemolytic Disease
OBJECTIVES: Quantitation of Rh antibodies is important clinically in predicting the risk of hemolytic disease of the newborn. We describe a flow cytometry method for the quantitation of anti-D antibodies that we developed in parallel to a recently described method. METHODS: As a secondary antibody we used whole IgG instead of Fab molecules. The advantages, besides lower cost, include a strong fluorescence signal with no need for amplification, and the possibility of diluting samples to minimize the risk of agglutination by IgM antibodies. We did extensive studies on reproducibility. RESULTS: Reproducibility was superior to the autoanalyzer method. The two methods were roughly in agreement in estimating low, medium, or high levels of anti-D with a correlation coefficient of 0.89. The autoanalyzer measures the in vitro agglutination of all anti-D antibodies whereas flow cytometry measures the amount of IgG anti-D bound to red cells, which is more like the in vivo situation. CONCLUSION: Further studies in a clinical setting will show whether flow-cytometric quantitation may improve the diagnostic value of anti-D concentration measurement.
5
Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.
P. J. BOWELL, J. S. Wainscoat, Tim Peto et al. · BMJ · 1982 · 95 citations · Full text